SCHEMBL29640136

SCHEMBL29640136

F[C@H]1CCN(Cc2cc(C(F)(F)F)nc3cn[nH]c23)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK1 Q13464 5/20 0.39
▸ CDC7 O00311 1/20 0.39
▸ CCNE1 P24864 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ DBF4 Q9UBU7 1/20 0.39
▸ ROCK2 O75116 8/20 0.35
▸ CCR2 P41597 4/20 0.33
▸ CNR2 P34972 2/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ DRD4 P21917 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ MAPK1 P28482 1/20 0.31
▸ DHODH Q02127 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ GRIN2B Q13224 1/20 0.31
▸ TLR7 Q9NYK1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31091993 0.77 DHODH (0.34) ROCK1CDC7CCNE1CDK2DBF4
SCHEMBL29640162 0.68 DGAT1 (0.34) —
SCHEMBL31091998 0.67 ADRB2 (0.37) MEN1KMT2AMAPK1
SCHEMBL30540536 0.67 LMNA (0.40) ROCK1CDC7DBF4ROCK2CCR2
SCHEMBL10850431 0.66 NT5E (0.42) ROCK1ALDH1A1
Lithium SCHEMBL31115361 0.63 KDM4E (0.38) ROCK1CDC7DBF4ROCK2CCR2
SCHEMBL30577604 0.63 GRM2 (0.41) ROCK2MEN1KMT2AALDH1A1GRM2
SCHEMBL30577588 0.63 GRM2 (0.41) ROCK2MEN1KMT2AALDH1A1GRM2
SCHEMBL30577649 0.63 HRH3 (0.38) ROCK1CDC7DBF4ROCK2CCR2
Lithium Ion SCHEMBL30540622 0.62 LMNA (0.39) ROCK1CDC7DBF4ROCK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450271-B Ureas, amino and substituted heteroaryl compounds for Cbl-b inhibition 纽力克斯治疗公司 2024-09-20 — — CN disclosed
CN-114450271-A Ureas, amino and substituted heteroaryl compounds for Cbl-b inhibition 纽力克斯治疗公司 2022-05-06 — — CN disclosed
Send feedback